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 Gums and joints: is there a connection? 
PART 1. EPIDEMIOLOGICAL AND CLINICAL LINK 
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ABSTRACT 
Rheumatoid arthritis (RA) and chronic periodontitis are common chronic 
inflammatory diseases that share numerous clinical and pathobiological 
characteristics. Due to their similarities, despite manifesting at anatomically 
distinct sites, the relationship between these two diseases has been 
investigated for many years. This review attempts to summarise the state of 
the field based on evidence published in the last 10 years.  
 
 
KEYPOINTS 
1. RA and periodontitis are epidemiologically linked 
2. The effect of periodontal therapy in RA remains unknown and more 
rigorous clinical trials are needed 
3. Rheumatologist and dentist should be aware of this link and work 
together for the benefit of the RA patient 
 
1. INTRODUCTION  
 
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that 
leads to the destruction of cartilage and bone in the joints. RA and chronic 
periodontitis are common chronic inflammatory diseases that share numerous 
clinical and pathobiological characteristics. The exacerbated immune reaction 
that arises in the gingival tissues of periodontitis patients leading to 
destruction of connective tissues and ultimately bone, is similar to the one 
occurring in the joints of RA patients. 1 Furthermore, these two diseases 
appear to be epidemiologically associated. 2 Due to their similarities, despite 
manifesting at anatomically distinct sites, the relationship between these two 
diseases has been investigated for many years. 
 
The link between Rheumatoid arthritis (RA) and Periodontal disease (PD) 
dates back to Hippocrates who observed that extraction of diseased teeth 
could cure arthritis. During the 1950s-60s the “total dental clearance” was 
commonly employed as part of the treatment regime for RA.3 More recently, 
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the upsurge in stratified medicine approaches to unravelling diseases 
mechanisms has brought into focus the link between PD and RA. The 
international workshop between the European Federation of Periodontology 
and the American Academy of Periodontology in 2013, lead to a call for more 
controlled clinical trials in this area and recommended an urgent need for 
research in this topic. 4 Since this workshop, a significant number of studies 
have investigated the PD-RA paradigm and this review attempts to 
summarise the state of the field based on evidence published in the last 
years.  
 
1.1. Prevalence of RA 
 
The prevalence of RA in the first world is believed to be increasing, currently 
affecting about 1-2% of the world’s population, with a male/ female ratio of 1:3 
and a peak incidence in the 4-5th decade of life. In the UK, the economic 
burden of RA is estimated to be more than £600 million 5 and these patients 
often suffer from comorbidities such as cardiovascular disease, which 
increases associated mortality. 6 
 
1.2. Pathogenesis of RA 
 
Whilst the trigger for the autoimmune reaction that leads to RA remains 
unknown, our understanding of the pathogenesis of RA has increased 
substantially over the last decade. The synovium of RA patients exhibits an 
elevated production of pro-inflammatory cytokines, including Tumor Necrosis 
Factor (TNF), Interleukins (IL) 1, 6, 15, 17, and granulocyte-macrophage 
colony-stimulating factor (GM-CSF). In the presence of these cytokines, T-
cells and synoviocytes activate osteoclast maturation, which leads to bone 
resorption in the joint (Figure 1). Moreover, the joint surface is encroached 
upon and destroyed by an anomalous fibrovascular coating, the pannus. 7, 8 
This constant state of inflammation and degradation of the joint structures 
causes chronic pain, fever, bone deformity, functional impairment and 
disability, classical features of inflammation.  
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Figure 1. Differences between the joint structure in rheumatoid arthritis (RA) 
and a healthy joint.  
 
1.3. Diagnosis and treatment of RA 
 
RA typically presents with swollen joints (often symmetrically), generalized 
pain, morning stiffness and movement limitations that last over an hour, and 
which can be reduced by gentle movements. These signs and symptoms help 
rheumatologists differentiate RA from osteoarthritis (OA), which is the most 
common form of joint disease, caused by cartilage degeneration and 
mechanical wear and tear. Interestingly, OA has not been found to be 
associated with chronic periodontitis and OA patients are frequently used as 
controls in studies that investigate the relationship between RA and PD. 2 9 10 
 
The latest criteria employed for the diagnosis of RA were formulated in 2010 
by the American College of Rheumatology (ACR)/European League Against 
Rheumatism (EULAR). This classification uses a score-based algorithm that 
considers type and number of joints involved, serological parameters 
(rheumatoid factor and anti citrullinated protein antibodies/ACPAs), acute-
phase reactants (C-reactive protein and erythrocyte sedimentation rate/ESR) 
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and duration of symptoms. 11 While rheumatoid factor can be present in in up 
to 20% of the general population, antibodies against citrullinated proteins 
(ACPA) are highly specific for RA. However, these antibodies are not present 
in all RA patients, therefore all clinical presentations of the criteria need to be 
considered necessary for the diagnosis of RA. 12 
 
 
 
The treatment of RA is complex and involves pharmacological and non-drug 
therapies including education, physical activity, occupational therapy and in 
late disease, joint replacement. The aim of pharmacological treatment of RA 
is to relieve pain, reduce inflammation and prevent destruction of cartilage 
and bone. This is usually achieved by the use of a combination of different 
drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), 
corticosteroids (oral or by injection), conventional disease-modifying anti-
rheumatic drugs (DMARDs) and biological therapies, a subcategory of 
DMARDs which targets specific steps of the inflammatory process, including 
TNF inhibitors, IL-6 inhibitors and anti-B-cell therapy. 13 
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2. CLINICAL EVIDENCE  
 
2.1. Epidemiological association between Periodontitis and RA 
 
For many years studies have investigated the association between 
periodontitis, tooth loss and rheumatoid arthritis (Table 1). While two of these 
studies reported negative results, the majority have reported a higher risk and 
prevalence of periodontitis in rheumatoid arthritis patients and vice versa 20, 23.  
 
Cross sectional studies have shown that patients with RA have a significantly 
increased prevalence of periodontitis compared to systemically healthy 
controls, with odds ratios (OR) ranging between 1.82 14 and 8.1 15.  
Furthermore, patients with periodontitis have a higher prevalence of RA, with 
OR ranging between 1.16 16 and 2.05. 17 Some of these studies, after 
adjusting for confounding factors, have demonstrated that the relationship 
appears independent of smoking 16, oral hygiene (plaque) 18, 15 and genetic 
factors. 19 
 
De Pablo and colleagues (2008) investigated this association using the 
National Health and Nutrition Examination Survey (NHANES), concluding that 
patients with RA had a higher prevalence of periodontitis (10-16%) compared 
to non-RA patients with 50% of RA subjects identified as edentulous. 
Although the cause of tooth loss was unknown, the authors concluded that 
these edentulous patients may be representative of severe cases of 
periodontitis, as RA patients had a lower frequency of restorations and caries. 
14 
 
In 2012 the European Federation of Periodontology (EFP) and American 
Academy of Periodontology (AAP) workshop on periodontal and systemic 
interrelationships concluded that the evidence of an association between RA 
and periodontitis was at least minimal but that more research was needed. 4 
Since then, more than 150 papers have been published in the field, including 
a large number of reviews, animal studies and 18 cohort studies. The cohort 
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studies were conducted in different countries around the world, some using 
very large data sets and only one reported no relationship. 20 
 
Using the Taiwanese National Health Insurance Research Database (NHIRD) 
cohort study which included 1,000,000 patients, a significant and independent 
association between RA and history of periodontitis was reported. 21 Another 
cohort study reported that from the 74 RA patients examined, 94% suffered 
from moderate to severe periodontitis (48% moderate and 46% severe). 22 
 
In contrast, there are also studies that have not reported such associations. In 
a large prospective cohort study, using data reported from 91,132 nurses 
followed over 12 years, there was no evidence of a higher risk of developing 
RA among patients  with periodontitis 23; however, in this study periodontitis 
was defined based on history of periodontal surgery through a self-reported 
questionnaire and no clinical examinations were conducted to diagnose 
periodontitis. More recently, no difference in the prevalence of periodontitis 
was observed in a Swedish case-control study including 2,740 RA patients. 
However, again in this study periodontitis was investigated by self-reporting 
questionnaire. 20 Thus, these two studies may be biased due to the 
recruitment methodology, as no clinical examination was used to diagnose 
periodontitis and therefore their conclusions may be misleading.  
 
The most recent systematic review and meta-analysis exploring the 
epidemiological evidence from 8 case control studies, concluded that there is 
a strong and significant association between RA and PD. However, the 
authors highlight the need for further rigorous studies using consistent case 
definitions for periodontitis and a more defined population to avoid bias due to 
invalid control groups. 24 
 
Although some of these case-control and cohort studies have clear limitations, 
there are now a large number of studies including thousands of patients from 
all over the world reporting an association.  
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Table 1. Summary of observational studies published since 2000 (with study 
population > 60) analysing the association between rheumatoid arthritis (RA) and 
periodontitis. Abbreviations: OR, odds ratio; RR, risk ratio; PlI, plaque index; GI, 
gingival index; RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide. 
Author & Year Study population Results Type of study 
Mercado et al., 
2000 25 
1412 patients 
attending dental 
hospital 
Periodontitis: 
higher 
prevalence of 
RA (3.95%) 
 
Cross 
sectional 
Mercado et al., 
2001 18 
65 patients (RA 
vs. non-RA) 
-RA: higher 
number of 
missing teeth, 
deeper pockets. 
No difference in 
bleeding or 
plaque index 
Case control 
Marotte et al., 
2006 19 
147 patients 
(RA) 
-Association 
between 
periodontal bone 
loss and wrist 
bone destruction  
(χ2 = 11.82) and 
shared epitope 
HLA-DR 
Cross 
sectional 
De Pablo et al., 
2008 14 
4,461 patients 
(NHANES III) 
-RA: higher 
prevalence of 
periodontitis 
(OR:1.82), 
edentulous 
(OR:2.27), less 
decay (p<0.001) 
Cross 
sectional 
Pischon et al., 
2008 15 
109 patients (57 
RA, 52 non-RA) 
RA: higher 
prevalence of 
periodontitis 
(OR:8.05), 
statistically 
significant after 
adjusting to 
confounding 
factors (Pl, GI) 
Case control 
Dissick et al., 
2009 10 
69 RA patients 
vs. 35 
Osteoarthritis 
(controls) 
patients 
-RA: higher 
prevalence of 
periodontitis and 
more severe  
-RA patients 
with periodontitis 
associated with 
Case control 
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RF positive and 
anti-CCP 
Arkema et al., 
2010 23 
81,132 patients 
(Nurses’ Health 
Study 
prospective 
cohort) 
No evidence of 
higher incidence 
of RA in 
periodontitis 
Cohort study 
Demmer et al., 
2011 17 
9,702 patients 
(NHANNES I) 
Periodontitis: 
higher 
prevalence of 
RA (OR:2.05) 
 
 
Cross 
sectional 
Potikuri et al., 
20120 16 
91 RA (DMARD 
naive, non-
smokers) vs 
healthy controls 
RA: higher 
prevalence of 
periodontitis 
(OR:4.28) 
Case control 
Smit et al., 2012 
26 
95 RA, 420 
matched 
controls 
RA: higher risk 
of periodontitis 
(RR: 3.7) 
Cross 
sectional 
Chen et al., 
2013 21 
13,779 newly 
diagnosed RA, 
137,790 non-RA 
periodontitis: 
higher 
prevalence of 
RA (OR:1.16) , 
Cohort study 
Monsarrat et al., 
2014 22 
74 RA patients 94% of RA had 
periodontitis 
(48% moderate 
and 46% 
severe) 
Cross 
sectional 
Eriksson et al., 
2016 20 
2,740 RA cases 
and 3,942 non-
RA 
No difference in 
periodontitis 
prevalence 
between groups 
Case control 
Bello-Gualtero 
JM, et al., 2016 
27 
119 Pre-RA; 48 
early-RA; 
Matched 
controls for both  
Significant 
association with 
periodontal 
disease and IgG 
against Pg 
Cross 
sectional 
Choi IA, et al.,  
2016 28 
264 RA and 88 
matched 
controls 
Higher 
prevalence of 
periodontitis in 
RA 
Cross 
sectional 
Ayravainen L, et 
al., 2017 29  
168 RA ad 168 
matched healthy 
controls 
RA patients had 
worse 
periodontal 
Cross section 
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condition 
 Schmickler J, et 
al., 2017 30 
53 RA DMARDs; 
28 RA 
unresponsive to 
DMARDs; 42 
controls 
RA patients had 
worse 
periodontal 
condition 
Prospective 
follow up 
study 
Ouedraogo DD, et 
al.,  2017 31 
 
43 RA; 86 
controls 
Prevalence of 
periodontitis 
higher in RA   
Case-control 
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2.2. Effects of periodontal treatment on RA  
 
Due to its high prevalence, scientists believe that periodontitis may represent 
an important modifiable risk factor for RA incidence and severity. If proven, 
treatment of periodontitis could offer a relatively inexpensive and safe, non-
pharmacological treatment with direct benefit for patients with RA.  
 
To date, 10 clinical studies and 3 systematic reviews have investigated the 
effect of periodontal therapy on RA, analysing different parameters. Their 
results suggest that treatment of periodontitis may have a significant positive 
effect on RA severity (Table 2). 32 33 However, most of the published studies 
are small, have short follow-up times following periodontal therapy, and 
investigate different outcome measures. 
 
Due to the heterogeneity of design in the various studies connecting RA and 
periodontitis, only a few parameters could be included for meta-analysis in the 
first systematic review considering the effects of treatment of periodontitis on 
RA outcomes; ESR being the only parameter found to be significantly reduced 
following periodontal treatment. 34 Another systematic review considering 
those same four studies concluded that although the RA “disease activity 
score” based on the 28 joint count (DAS28) appeared to be consistently 
improved following periodontal therapy throughout the four trials, further RCTs 
were needed. 2 The latest systematic review conducted by Caldeloro included 
4 studies from 2005 to 2013 and the authors concluded that there was a 
significant reduction of DAS28 following periodontal therapy. 35 Since then, 
three studies have been published, all of them reporting a significant 
improvement of RA parameters after periodontal therapy. 36-38  
 
Although these results are promising, some authors have failed to observe 
this effect. In a case report of one RA patient undergoing periodontal 
treatment for 15 years, no beneficial effect was reported. 39 Pinho and 
collaborators conducted a clinical trial in which they observed no reduction in 
acute phase reactants following periodontal therapy in RA, and systemic 
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markers of inflammation did not correlate with observed improvements in 
periodontal health. 40 More recently, Kurgan reported a positive effect of 
periodontal treatment on gingival crevicular fluid (GCF) levels of a marker of 
systemic inflammation, plasminogen activator-2, in 15 patients with 
periodontitis with or without rheumatoid arthritis but he found no effect on RA 
parameters. 41  
 
Although in the workshop between the EFP and the AAP in 2013, it was 
concluded that more rigorous controlled clinical trials and research were 
needed in the field, 4 the studies published since the workshop continue to  
utilise a short follow-up period (ranging between 8 weeks and 6 months) and 
a small sample size (<75 patients). Furthermore, each study employed 
different definitions of periodontitis and used different parameters to measure 
RA status, with the DAS28 Disease Activity Score being the most widely 
reported, based on subjective measures, such as the Visual Analog Scale 
(VAS) for pain and number of tender joints.  
 
Therefore, although the current evidence suggests that there is an 
improvement in RA parameters after periodontal therapy, investigators in the 
field agree that longer and more rigorous randomized controlled trials are 
necessary to definitively determine the effects of periodontal treatment on RA.  
 
Importantly, a recent systematic review considering the effect of periodontitis 
upon the response of RA patients to medication, found that persistent 
periodontal inflammation hampers the effect of anti-TNF drugs. 42 Therefore, 
the treatment of periodontitis may also benefit the efficiency of 
pharmacological interventions in RA.   
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Table 2. Clinical trials evaluating the effect of periodontal therapy in Rheumatoid 
arthritis (RA). Abbreviations: PD, periodontitis; RA, Rheumatoid Arthritis; RF, 
Rheumatoid Factor, ESR, Erythrocyte Sedimentation Rate; HAQ, Health 
Assessment Questionnaire; DAS, Disease Activity Score; VAS, Visual Analogue 
Scale; TNF, Tumor Necrosis Factor; CRP, C-Reactive Proteins; AAG, alpha-1 
acid glycoprotein. 
 
Author&Year Duration  Patient number Parameters 
evaluated 
Results 
Ribeiro 2005 
32 
 
3 months  42 RA+PD 
-16 periodontal 
treatment 
-26 oral hygiene 
and 
supragingival 
cleaning 
RF, ESR, HAQ ESR significantly 
reduced 
Al-katma  
2007 43 
 
8 
weeks 
29 RA+PD 
-17 
periodontal 
treatment 
-12 no 
treatment 
DAS 28, ESR VAS, DAS 28 
and ESR 
reduced 
Ortiz 
2009 44 
 
8 
weeks 
40 RA+PD 
-10 
periodontal 
treatment and 
DMARDs 
only. 
-10 
periodontal 
treatments 
and DMARDs 
with anti-TNF 
drugs. 
-10 no 
periodontal 
therapy, 
DMARDs 
only 
-10 no 
periodontal 
treatment, 
DMARDs with 
anti-TNF 
drugs. 
ESR, TNF-
alpha, signs 
and 
symptoms 
VAS and 
DAS 28 
improved in 
treatment 
groups. 
ESR not 
significantly 
reduced 
Anti-TNF 
drugs 
improved 
PPD and CAL 
13 | P a g e  
 
Pinho 
2009 40 
 
6 
months 
75 patients: 
-15 RA+PD 
with 
periodontal 
treatment 
-15 RA+PD 
no 
periodontal 
treatment 
-15 PD with 
periodontal 
treatment 
-15 PD no 
periodontal 
treatment 
DAS 28, 
CRP, ESR, 
AAG (alpha-1 
acid 
glycoprotein) 
No clear 
relation. 
AAG, ESR 
and CRP not 
significantly 
reduced with 
periodontal 
therapy. 
Okada 
2013 45 
8 
weeks 
55 RA+PD 
-26 
supragingival 
cleaning 
-29 no 
treatment 
DAS 28, 
CRP, anti-
CCP, RF, 
TNF-alpha  
and levels of 
IgG to P. 
gingivalis 
Reduction of 
DAS 28 and 
levels of IgG 
to P.gingivalis 
and citrulline. 
Erciyas 
2013 33 
3 
months 
60 RA and 
PD 
-30 RA 
moderate-
severe 
disease 
activity 
-30 RA low 
disease 
activity 
ESR, CRP, 
TNF-alpha, 
DAS28  
 
Significant 
reduction of  
ESR, CRP, 
TNF-alpha, 
DAS28  
 
Biyikoglu 
2013 46 
6 
months 
15 RA PD, 15 
RA healthy 
DAS 28, 
GCF, serum 
IL-1β, TNF-α 
Significant 
decreases in 
DAS28 and 
gingival 
crevicular 
fluid 
interleukin-1 
Roman-
Torres 
2015 36 
90 
days 
12 RA and 12 
controls 
CRP and 
ESR 
Improvement 
after 
periodontal 
therapy (mild 
periodontitis) 
Khare 
2016 37 
3 
months 
60 RAPD 
patients 
DAS, ESR, 
CRP 
Significant 
improvement 
of DAS 28 
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and CRP 
after 
periodontal 
therapy 
Zhao 
2018 38 
1 
month 
-18 PD 
patients  
-18 RA 
patients  
-18 RA with 
PD patients  
-10 healthy 
controls  
anti-CCP, 
CRP, DAS 
28, 
periodontal 
parameters 
Significant 
decrease of 
all RA 
parameters in 
treatment 
group 
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 3. SUMMARY AND CONCLUSIONS  
 
Numerous studies have reported an epidemiological link between RA and 
periodontitis and although some studies did not find such associations, the 
shortcomings of these studies may well explain their negative results. 
Although numerous epidemiological studies conducted in the past have 
employed inconsistent definitions of periodontitis, the most recent studies 
have overcome this problem and also include larger numbers of patients. 
Therefore, considering the evidence, there appears to be a clear 
epidemiological relationship between RA and periodontitis. 
 
Although there is sufficient evidence for an epidemiological link between RA 
and periodontitis, the directionality of this relationship is not known. Large-
scale longitudinal studies are needed to explore whether periodontitis 
increases the risk of incident RA and vice versa. Therefore, future research 
investigating the oral microbiome, inflammatory response and autoimmune 
response of patients at risk to develop RA, RA patients and periodontitis 
patients, is needed to clarify gaps in the literature. 
 
While an increasing number of small clinical studies have shown a trend to an 
amelioration of surrogate measures of RA following periodontal treatment, 
controlled clinical trials with longer follow up periods and larger numbers of 
patients are needed to corroborate this hypothesis. If proven, periodontal 
therapy could be a relatively inexpensive, non-pharmaceutical method of 
improving RA in addition to the known local and systemic benefits of 
maintaining periodontal health.  
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